Critical micellar concentration shifting as a simple tool for evaluating cyclodextrin/enhancer interactions

International Journal of Pharmaceutics

Volumn 127, Issue 2, 1996, Pages 239-244

  Martini, A ^a   Artico, R ^a   Civaroli, P ^a   Muggetti, L ^a   De Ponti, R ^a  

^a Pharmacia   (Italy)

Author keywords

critical micellar concentration; cyclodextrins; penetration enhancers; reduction of toxicity; surface tension

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BENZALKONIUM; BETA CYCLODEXTRIN; CETYLPYRIDINIUM SALT; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; GLYCODEOXYCHOLIC ACID; PENETRATION ENHANCING AGENT; POLIDOCANOL; TAURODEOXYCHOLIC ACID;

ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; IONIC STRENGTH; MICELLE; PRIORITY JOURNAL; SURFACE TENSION;

EID: 0029927678     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04229-6     Document Type: Article

References (6)

1. Bekers, O., Uijtendaal, E.V., Beijnen, J.H., Bult, A. and Underberg, W.J.M., Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm., 17 (1991) 1503-1549.
2. De Ponti, R. and Lardini, E., Use of chemical enhancers for nasal drug delivery. Drug Dev. Ind. Pharm., 17 (1991) 1419-1436.
3. Jabbal Gill, I., Illum, L., Farraj, N. and De Ponti, R., Cyclodextrins as protection agents against enhancer damage in nasal delivery systems I. Assessment of effect by measurement of erythrocyte haemolysis. Eur. J. Pharm. Sci., 1 (1994a) 229-236.
4. Jabbal Gill, I., Fisher, A.N., Hinchcliffe, A., Whetstone, J., Farraj, N., De Ponti, R. and Illum, L., Cyclodextrins as protection agents against enhancer damage in nasal delivery systems I. Effect on in vivo absorption of insulin and hystopathology of nasal membrane. Eur. J. Pharm. Sci., 1 (1994b) 237-248.
5. Martin, A., Swarbrick, J. and Cammarata, A., Physical Pharmacy, 3rd edn., Lea and Febiger, Philadelphia, PA, 1983, pp. 237-241.
6. Nakanishi, K., Nadai, T., Masada, M. and Miyajima, K., Effect of cyclodextrins on biological membrane. II. Mechanism of the enhancement of the intestinal absorption of non-absorbable drug by cyclodextrins. Chem. Pharm. Bull., 40 (1990) 1252-1256.